# Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

> **NCT00189943** · PHASE1 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 90 (—)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** MVA-BN

## Key facts

- **NCT ID:** NCT00189943
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** 90 (—)
- **Last updated:** 2005-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189943, "Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00189943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*